DOCA-salt rat is characterized by low renin-AngII levels [27, 28], and BBB permeability is sustained in the early stage (at least 3 weeks after DOCA-salt administration) of hypertension in DOCA-salt rat [27, 29]. This evidence concerns the gene REN and Hypertension.